Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 12;13(8):1505-1520.
doi: 10.3390/ejihpe13080110.

Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review

Lizeth Sepúlveda-Lizcano  1 , Vivian Vanessa Arenas-Villamizar  1 , Enna Beatriz Jaimes-Duarte  2 , Henry García-Pacheco  3   4 , Carlos Silva Paredes  4   5 , Valmore Bermúdez  6 , Diego Rivera-Porras  1
Affiliations
Review

Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review

Lizeth Sepúlveda-Lizcano et al. Eur J Investig Health Psychol Educ. .

Abstract

This review aimed to investigate the metabolic alterations associated with psychopharmacological treatment of neuropsychiatric disorders, which can significantly impact patients' physical health and overall quality of life. The study utilized the PRISMA methodology and included cross-sectional, retrospective studies, and randomized clinical trials from reputable databases like SCOPUS, CLARIVATE, SCIENCE DIRECT, and PUBMED. Out of the 64 selected studies, various psychotropic drug classes were analyzed, including antidepressants, anticonvulsants, and antipsychotics. Among the antidepressants, such as amitriptyline, Imipramine, and clomipramine, weight gain, constipation, and cardiovascular effects were the most commonly reported metabolic adverse effects. SSRI antidepressants like Fluoxetine, Sertraline, Citalopram, Escitalopram, and Paroxetine exhibited a high prevalence of gastrointestinal and cardiac alterations. Regarding anticonvulsants, valproic acid and Fosphenytoin were associated with adverse reactions such as weight gain and disturbances in appetite and sleep patterns. As for antipsychotics, drugs like Clozapine, Olanzapine, and Risperidone were linked to weight gain, diabetes, and deterioration of the lipid profile. The findings of this review emphasize the importance of continuous monitoring for adverse effects, particularly considering that the metabolic changes caused by psychopharmacological medications may vary depending on the age of the patients. Future research should focus on conducting field studies to further expand knowledge on the metabolic effects of other commonly prescribed psychotropic drugs. Overall, the study highlights the significance of understanding and managing metabolic alterations induced by psychopharmacological treatment to enhance patient care and well-being.

Keywords: anticonvulsants; antidepressants; antipsychotics; metabolism; psychopharmacological treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Graphical representation of the PRISMA flow * p < 0.05, ** p < 0.01.
See this image and copyright information in PMC

References

    1. Rojas E., Castro A., Manzano A., Suárez M.K., Lameda V., Carrasquero R., Nava M., Bermúdez V. Diagnostic Criteria and Management of Metabolic Syndrome: Evolution Overtime. Gac. Medica Caracas. 2021;128:480–504. doi: 10.47307/GMC.2020.128.4.5. - DOI
    1. Moreira F.P., Jansen K., Cardoso T.D.A., Mondin T.C., Magalhães P.V., Kapczinski F., Souza L.D.M., da Silva R.A., Oses J.P., Wiener C.D. Metabolic Syndrome and Psychiatric Disorders: A Population-Based Study. Rev. Bras. Psiquiatr. 2019;41:38–43. doi: 10.1590/1516-4446-2017-2328. - DOI - PMC - PubMed
    1. Tubbs A.S., Khader W., Fernandez F., Grandner M.A. The Common Denominators of Sleep, Obesity, and Psychopathology. Curr. Opin. Psychol. 2020;34:84–88. doi: 10.1016/j.copsyc.2019.11.003. - DOI - PMC - PubMed
    1. Sugai T., Suzuki Y., Yamazaki M., Shimoda K., Mori T., Ozeki Y., Matsuda H., Sugawara N., Yasui-Furukori N., Minami Y., et al. High Prevalence of Obesity, Hypertension, Hyperlipidemia, and Diabetes Mellitus in Japanese Outpatients with Schizophrenia: A Nationwide Survey. PLoS ONE. 2016;11:e0166429. doi: 10.1371/journal.pone.0166429. - DOI - PMC - PubMed
    1. Zimmet P., Alberti K.G.M.M., Shaw J. Global and Societal Implications of the Diabetes Epidemic. Nature. 2001;414:782–787. doi: 10.1038/414782a. - DOI - PubMed